Extracellular vesicles derived from GMSCs stimulated with TNF-α and IFN-α promote M2 macrophage polarization via enhanced CD73 and CD5L expression
-
- 渡邊, ゆかり
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 福田, 隆男
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 林, 千華子
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 中尾, 雄紀
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 豊田, 真顕
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 川上, 賢太郎
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 新城, 尊徳
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 岩下, 未咲
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 大和, 寛明
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 四本, かれん
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 武富, 孝治
- 聖マリア病院
-
- 内海, 健
- 九州大学大学院医学研究院
-
- 讃井, 彰一
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
-
- 西村, 英紀
- 九州大学大学院歯学研究院口腔機能修復学歯周病学
説明
Immunoregulatory properties of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) are promising. Gingival tissue-derived MSCs (GMSCs) have unique immunoregulatory capacity and secrete large amounts of EVs. Recent findings suggest that priming MSCs with inflammatory stimuli is an effective strategy for cell-free therapy. However, the precise mechanism by which the contents of EVs are customized has not been fully elucidated. Here, we show that EVs derived from GMSCs primed with a combination of two pro-inflammatory cytokines, tumor necrosis factor-α (TNF-α) and interferon-α (IFN-α), synergistically promote anti-inflammatory M2 macrophage polarization by increasing the expression of cluster of differentiation 73 (CD73) and CD5 molecule-like (CD5L). Expression of CD73 by TNF-α/IFN-α stimulation was transcriptionally upregulated by the activation of mammalian target of rapamycin signaling and nuclear translocation of hypoxia-inducible factor 1α in GMSCs. TNF-α/IFN-α treatment also significantly increased the expression of CD5L mRNA via the transcription factor DNA-binding protein inhibitor ID3 and liver X receptor. Interestingly, exosomal CD5L is a prerequisite for the synergistic effect of EVs-mediated M2 macrophage polarization. These results indicate that combined pre-licensing with TNF-α and IFN-α in GMSCs is ideal for enhancing the anti-inflammatory function of EVs, which contributes to the establishment of a therapeutic tool.
収録刊行物
-
- Scientific Reports
-
Scientific Reports 12 13344-, 2022-08-03
Springer
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1050582772438261248
-
- ISSN
- 20452322
-
- HANDLE
- 2324/7161506
-
- PubMed
- 35922474
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- IRDB
- Crossref
- KAKEN
- OpenAIRE